Use of genotypic HIV DNA testing: a DELPHI-type consensus.

ABSTRACT:

Objectives

As many disparities in the clinical use of HIV DNA sequencing are observed, a DELPHI-type consensus was initiated in France to homogenize use, techniques and interpretation of results.

Methods

Based on a literature review and clinical experience, a steering committee (SC) of eight virologists and one infectious disease specialist formulated statements. Statements were submitted to an independent and anonymous electronic vote of virologists and HIV clinicians in France, between October 2022 and December 2022.

Results

The SC developed 20 statements grouped into six categories: clinical situations for the use of HIV DNA genotyping; techniques for performing HIV DNA genotyping; consideration of apolipoprotein B mRNA editing enzyme (APOBEC) mutations; genotyping

SUBMITTER: Andre-Garnier E 

PROVIDER: S-EPMC10904721 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature